Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?

Rudnick MR, Leonberg-Yoo AK, Litt HI, Cohen RM, Hilton S, Reese PP.

Am J Kidney Dis. 2019 Aug 28. pii: S0272-6386(19)30844-3. doi: 10.1053/j.ajkd.2019.05.022. [Epub ahead of print] Review.

PMID:
31473019
2.

Lactic Acidosis and The Role of Sodium Bicarbonate: A Narrative Opinion.

Rudnick MR, Blair GJ, Kuschner WG, Barr J.

Shock. 2019 Jul 16. doi: 10.1097/SHK.0000000000001415. [Epub ahead of print]

PMID:
31318832
3.

Medical Student Participation in Patient- and Family-Centered Rounding: A National Survey of Pediatric Clerkships.

Trost MJ, Potisek NM, Seltz LB, Rudnick M, Mamey MR, Long M, Quigley PD.

Acad Pediatr. 2019 Jul;19(5):549-554. doi: 10.1016/j.acap.2018.12.010. Epub 2019 Jan 11.

PMID:
30639761
4.

Opportunities to Improve Inpatient Care for Children With Behavioral Comorbidities.

Rudnick M, Henry K, Trost M.

Hosp Pediatr. 2019 Jan;9(1):61-63. doi: 10.1542/hpeds.2018-0110. No abstract available.

PMID:
30567712
5.

Bilateral Renal Infarctions During the Use of Sumatriptan.

Abramovitz B, Leonberg-Yoo A, Bahrainwala JZ, Litt H, Rudnick MR.

Kidney Int Rep. 2018 May 16;3(5):1233-1236. doi: 10.1016/j.ekir.2018.05.003. eCollection 2018 Sep. No abstract available.

6.

Nonpharmacologic and Medication Minimization Strategies for the Prevention and Treatment of ICU Delirium: A Narrative Review.

Blair GJ, Mehmood T, Rudnick M, Kuschner WG, Barr J.

J Intensive Care Med. 2018 Jan 1:885066618771528. doi: 10.1177/0885066618771528. [Epub ahead of print]

PMID:
29699467
7.

Tobacco Use: A Chronic Kidney Disease Accelerant.

Leonberg-Yoo AK, Rudnick MR.

Am J Nephrol. 2017;46(4):257-259. doi: 10.1159/000481209. Epub 2017 Sep 21. No abstract available.

8.

Use of Radiocontrast Agents in CKD and ESRD.

Bahrainwala JZ, Leonberg-Yoo AK, Rudnick MR.

Semin Dial. 2017 Jul;30(4):290-304. doi: 10.1111/sdi.12593. Epub 2017 Apr 5. Review.

PMID:
28382626
9.

Faith-Based Organizations and Veteran Reintegration: Enriching the Web of Support.

Werber L, Derose KP, Rudnick M, Harrell MC, Naranjo D.

Rand Health Q. 2015 Nov 30;5(2):15. eCollection 2015 Nov 30.

10.

Hemodynamic monitoring during liver transplantation: A state of the art review.

Rudnick MR, Marchi LD, Plotkin JS.

World J Hepatol. 2015 Jun 8;7(10):1302-11. doi: 10.4254/wjh.v7.i10.1302. Review.

11.

Oxalic acid: a signal molecule for fungus-feeding bacteria of the genus Collimonas?

Rudnick MB, van Veen JA, de Boer W.

Environ Microbiol Rep. 2015 Oct;7(5):709-14. doi: 10.1111/1758-2229.12290. Epub 2015 Jun 10.

PMID:
25858310
12.

Early colonizers of unoccupied habitats represent a minority of the soil bacterial community.

Wolf AB, Rudnick MB, de Boer W, Kowalchuk GA.

FEMS Microbiol Ecol. 2015 May;91(5). pii: fiv024. doi: 10.1093/femsec/fiv024. Epub 2015 Mar 15.

PMID:
25778508
13.

Process Evaluation of the New Mexico Maternal, Infant, and Early Childhood Home Visiting Competitive Development Grant.

Chinman M, Hunter SB, Cannon JS, Kilburn MR, Harvey M, Rudnick M.

Rand Health Q. 2014 Dec 30;4(3):3. eCollection 2014 Dec 30.

14.

Relative Nephrotoxicity of Different Contrast Media.

Aqeel I, Garcha AS, Rudnick MR.

Interv Cardiol Clin. 2014 Jul;3(3):349-356. doi: 10.1016/j.iccl.2014.04.001. Epub 2014 Jun 28. Review.

PMID:
28582219
15.

How does the nephrologist manage an LVAD patient on chronic maintenance dialysis?

Patel AM, Eduardo Rame J, Rudnick MR.

Semin Dial. 2014 May-Jun;27(3):284-8. doi: 10.1111/sdi.12229. Epub 2014 Mar 21. No abstract available.

PMID:
24650366
16.

Investigation of a potential protective mechanism against heparin-induced thrombocytopenia in patients on chronic intermittent hemodialysis.

Tanhehco YC, Cuker A, Rudnick M, Sachais BS.

Thromb Res. 2013 Mar;131(3):244-8. doi: 10.1016/j.thromres.2012.12.010. Epub 2013 Jan 8.

17.

Renal failure in patients with left ventricular assist devices.

Patel AM, Adeseun GA, Ahmed I, Mitter N, Rame JE, Rudnick MR.

Clin J Am Soc Nephrol. 2013 Mar;8(3):484-96. doi: 10.2215/CJN.06210612. Epub 2012 Oct 11. Review.

18.

Measuring enactment of innovations and the factors that affect implementation and sustainability: moving toward common language and shared conceptual understanding.

Century J, Cassata A, Rudnick M, Freeman C.

J Behav Health Serv Res. 2012 Oct;39(4):343-61. doi: 10.1007/s11414-012-9287-x.

PMID:
22948708
19.

The case for primary placement of tunneled hemodialysis catheters in acute kidney injury.

Coryell L, Lott JP, Stavropoulos SW, Mondschein JI, Patel AA, Kwak A, Soulen MC, Solomon JA, Shlansky-Goldberg RD, Nemeth AA, Kobrin S, Rudnick M, Trerotola SO.

J Vasc Interv Radiol. 2009 Dec;20(12):1578-81; quiz 1582. doi: 10.1016/j.jvir.2009.08.014.

PMID:
19944983
20.

Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.

Laskey W, Aspelin P, Davidson C, Rudnick M, Aubry P, Kumar S, Gietzen F, Wiemer M; DXV405 Study Group.

Am Heart J. 2009 Nov;158(5):822-828.e3. doi: 10.1016/j.ahj.2009.08.016.

PMID:
19853704
21.

Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.

Rudnick MR, Davidson C, Laskey W, Stafford JL, Sherwin PF; VALOR Trial Investigators.

Am Heart J. 2008 Oct;156(4):776-82.

PMID:
18946896
22.

Clinical significance and preventive strategies for contrast-induced nephropathy.

Sterling KA, Tehrani T, Rudnick MR.

Curr Opin Nephrol Hypertens. 2008 Nov;17(6):616-23. doi: 10.1097/MNH.0b013e32830f45a3. Review.

PMID:
18941356
23.

Contrast-induced nephropathy: what are the true clinical consequences?

Rudnick M, Feldman H.

Clin J Am Soc Nephrol. 2008 Jan;3(1):263-72. doi: 10.2215/CJN.03690907. Review.

24.

Contrast-induced nephropathy: is the picture any clearer?

Rudnick MR, Goldfarb S, Tumlin J.

Clin J Am Soc Nephrol. 2008 Jan;3(1):261-2. Epub 2007 Dec 12. Review. No abstract available.

25.

Contrast-induced nephropathy: how it develops, how to prevent it.

Rudnick MR, Kesselheim A, Goldfarb S.

Cleve Clin J Med. 2006 Jan;73(1):75-80, 83-7. Review.

PMID:
16444919
26.

Religiosity in a hemodialysis population and its relationship to satisfaction with medical care, satisfaction with life, and adherence.

Berman E, Merz JF, Rudnick M, Snyder RW, Rogers KK, Lee J, Johnson D, Mosenkis A, Israni A, Wolpe PR, Lipschutz JH.

Am J Kidney Dis. 2004 Sep;44(3):488-97.

PMID:
15332222
27.

Hemodialysis-related venous stenosis: treatment with ultrahigh-pressure angioplasty balloons.

Trerotola SO, Stavropoulos SW, Shlansky-Goldberg R, Tuite CM, Kobrin S, Rudnick MR.

Radiology. 2004 Apr;231(1):259-62.

PMID:
15068951
28.

N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.

Fishbane S, Durham JH, Marzo K, Rudnick M.

J Am Soc Nephrol. 2004 Feb;15(2):251-60. Review.

29.

Use of electrotherapy to reverse expanding cutaneous gangrene in end-stage renal disease.

Goldman RJ, Brewley BI, Cohen R, Rudnick M.

Adv Skin Wound Care. 2003 Dec;16(7):363-6. No abstract available.

PMID:
14688644
30.
31.

Screening positive urine pregnancy tests for sexually transmitted diseases expedites the treatment of infected adolescent gravidas.

Stevens-Simon C, Rudnick M, Beach RK, Weinberg A.

J Matern Fetal Neonatal Med. 2002 Jun;11(6):391-5.

PMID:
12389654
32.

Molecular mechanisms regulating myogenic determination and differentiation.

Perry RL, Rudnick MA.

Front Biosci. 2000 Sep 1;5:D750-67. Review.

PMID:
10966875
33.

Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.

Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N, Schwab SJ.

Kidney Int. 2000 Apr;57(4):1675-80.

34.

Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease.

Berns JS, Rudnick MR, Cohen RM, Bower JD, Wood BC.

Kidney Int. 1999 Jul;56(1):253-60.

35.

Bromfenac disposition in patients with impaired kidney function.

Ermer JC, Boni JP, Cevallos WH, DeCleene S, Burghart P, Rudnick MR, Fruncillo RJ, Berns JS, Cohen RM.

Clin Pharmacol Ther. 1997 Mar;61(3):312-8.

PMID:
9084456
36.

Contrast media-associated nephrotoxicity.

Rudnick MR, Berns JS, Cohen RM, Goldfarb S.

Semin Nephrol. 1997 Jan;17(1):15-26. Review.

PMID:
9000546
37.

Contrast media-associated nephrotoxicity.

Rudnick MR, Berns JS, Cohen RM, Goldfarb S.

Curr Opin Nephrol Hypertens. 1996 Mar;5(2):127-33. Review.

PMID:
8744533
38.

Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients.

Berns JS, Haghighat A, Staddon A, Cohen RM, Schmidt R, Fisher S, Rudnick MR, Tomaszewski JE.

Cancer. 1995 Aug 1;76(3):497-500.

PMID:
8625132
39.

Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients.

Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick MR, Benz RL.

Am J Kidney Dis. 1995 Apr;25(4):548-54.

PMID:
7702049
40.

Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.

Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB.

Kidney Int. 1995 Jan;47(1):254-61.

41.

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.

Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW Jr, Shadur CA, et al.

Am J Kidney Dis. 1994 Nov;24(5):777-84.

PMID:
7977319
42.

Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review.

Rudnick MR, Berns JS, Cohen RM, Goldfarb S.

Am J Kidney Dis. 1994 Oct;24(4):713-27. Review.

PMID:
7942832
43.

Acute renal failure after intravenous immunoglobulin therapy.

Pasatiempo AM, Kroser JA, Rudnick M, Hoffman BI.

J Rheumatol. 1994 Feb;21(2):347-9.

PMID:
8182648
44.

Low-osmolality contrast media and the risk of contrast-associated nephrotoxicity.

Goldfarb S, Spinler S, Berns JS, Rudnick MR.

Invest Radiol. 1993 Nov;28 Suppl 5:S7-10; discussion S11-2. Review.

PMID:
8282507
45.

Fatty acylated toxin structure.

Branton WD, Rudnick MS, Zhou Y, Eccleston ED, Fields GB, Bowers LD.

Nature. 1993 Oct 7;365(6446):496-7. No abstract available.

PMID:
8413602
46.

Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study.

Hill JA, Winniford M, Cohen MB, Van Fossen DB, Murphy MJ, Halpern EF, Ludbrook PA, Wexler L, Rudnick MR, Goldfarb S.

Am J Cardiol. 1993 Oct 1;72(11):770-5.

PMID:
8213508
48.

Hypoglycemia with hyperinsulinemia in a chronic hemodialysis patient following parathyroidectomy.

Nadkarni M, Berns JS, Rudnick MR, Cohen RM.

Nephron. 1992;60(1):100-3.

PMID:
1738397
49.

Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease.

Berns JS, Rudnick MR, Cohen RM.

Am J Kidney Dis. 1991 Jul;18(1):143. No abstract available.

PMID:
2063850
50.

Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.

Berns JS, Cohen RM, Stumacher RJ, Rudnick MR.

J Am Soc Nephrol. 1991 Mar;1(9):1061-80. Review.

Supplemental Content

Loading ...
Support Center